ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,345, issued on March 25, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).
"Pyrrolo[3,2-cisoquinoline-2,3-dione compounds as CK2 inhibitors" was invented by Christophe Tratrat (Al-Ahsa, Saudi Arabia) and Michelyne Haroun (Al-Ahsa, Saudi Arabia).
According to the abstract* released by the U.S. Patent & Trademark Office: "Novel pyrrolo[3,2-c]isoquinoline-2,3-diones, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The pyrrolo[3,2-c]isoquinoline-2,3-dione compounds, identified as CK2 inhibitors, are useful as anticancer and/or antitumor agents, and as agents for...